Innovative business development in the Lithuanian capital
Vilnius City Innovation Industrial Park is the first and only industrial park in the capital of Lithuania, dedicated exclusively to the development of innovative business.
24 ha VCIIP territory is surrounded by national forests and already has a fully developed infrastructure. It is dedicated to Lithuanian and foreign companies that want to build research centres, laboratories or factories, as well as to business and science collaboration; nearby are some of the best universities in Lithuania, as well as main science centres.
In 2015, VCIIP was granted the status of a national importance economic project.
The obvious reasons to apply
Strategical location and great access
VCIIP is situated in Vilnius city, 30 minutes from the old town, the railway and bus stations, and the international airport. Three public transport stops – „Inovacijų pramonės parkas”, „Miškadvario” and „Vismaliukai” – are located in VCIIP. Although city life is really close by, the area is conveniently situated away from the street noise, surrounded by national forests.
The industrial park already has a developed infrastructure, from engineering networks to communications. All you have to do is apply and settle down.
Partnership oriented community
VCIIP was created exclusively for innovative companies that are operating in the seven areas of smart specialisation. It encourages partnership and clustering between its customers in order to take full advantage of the VCIIP community’s benefits.
The merge of science and business
VCIIP is part of the Integrated Science, Studies and Business Valley “Sauletekis” program. Nearby are two of the best Lithuanian universities and their campuses, three science centres, two science and technology parks, as well as excellent conditions for R&D infrastructure development and human resource management.
From startup to investor
VCIIP is open to companies of all sizes: from successful global companies to start-ups.
Status of national importance. No infrastructure charge
In 2015 VCIIP was granted the status of economic project of national importance that is strengthening the Lithuanian innovation system. Therefore, infrastructure development charge is not applied to the investors establishing at VCIIP.
VCIIP has been in operation since August, 2018.
Already reached results
€ 33 759 235
New job openings
Life Sciences Incubator
By 2022 a specialized life sciences incubator – Technology Development Center – will be built at VCIIP, offering unique laboratory facilities specialized for work with microorganisms, viruses and bacteria.
4000 sq. m. incubator will host 2 open access centers, with infrastructure and services accessible not only to the startups residing here, but for other innovative companies as well. Moreover, we estimate that by 2035 over 80 life sciences startups will have benefited from the incubator’s services.
Life Sciences Digital Innovation Hub (LS DIH Lithuania) Cluster is a platform for business-research partnership, dedicated to fostering digital innovation in the life sciences, bringing together research, business and public sector institutions and organizations.
Industrial Park Plan
- Subleased lands
- Operator of VCIIP
- VCIIP operator‘s Science and Business Incubator (until the end of 2022)
- Land for long-term sublease
- State forest / Public areas
- Planned streets
- Forests / Residential areas
- Reserved lands
Customers and partners’ comments
The ability to establish and adapt infrastructure to our needs comes rarely, especially in such a convenient location. We see the proximity of creative companies and research institutions in the park as an opportunity to strengthen business-business and science-business synergies, which will help to implement complex projects more efficiently. No less important reason – we believe in Vilnius as a city where the highest-level professionals would like to live and create, we believe in the vision and mission of the Park. Therefore, the decision to settle at VCIIP was very simple.
“Our decision to settle at VCIIP is based on several reasons – it is a convenient location with developed infrastructure, rapidly growing VCIIP life sciences community, and of course – the value proposition itself, which allows us to plan the rapid development of the company. In preparation for the expansion of the production of immunological diagnostic tests and their components, we are going to set up a factory and laboratory to develop new products at VCIIP by the end of 2023. It’s an important move which will help us to grow the company’s scientific and innovative potential in the future.”
“The VCIIP management team is highly oriented to life sciences sector growth and has put significant effort into accommodating our requirements and helping us grow.”
„Our main goal is to expand our business in the high-tech field, which requires highly qualified professionals and large-scale research as well as collaboration with research institutions or private companies in the biotechnology sector. Therefore, the opportunity to set up in Vilnius City Innovation Industrial Park proved to be attractive not only because of its convenient location and well-developed infrastructure, but also because of the strong life sciences companies that are developing there.”
“We have chosen VCIIP because of its amazing location — it gave us the opportunity to develop next to innovative modern companies, thus improving positions by attracting potential investors and commercial partners. Plus, nearby is Vilnius Gediminas Technical University.”
“The opportunity to settle down in the Vilnius City Innovation Industrial Park seemed attractive due to the existing infrastructure, as well as great VCIIP strategy to create an ecosystem of innovations and good financial value. Continuing smooth and expeditious communication with the operator, its flexibility in dealing with various issues and finding the best solution has helped to make a definite investment in the park.”
“Gensinta”, a start-up operating in the field of synthetic biology, will establish in Vilnius City Innovation Industrial Park
Northtown Vilnius, the operator of VCIIP, has signed an agreement with “Gensinta”, which is developing a new generation DNA synthesis technology based on molecular biology and photonics methods. “Gensinta” plans to fully establish in Vilnius City Innovation Industrial Park by August 2023, and the company’s investment in VCIIP is expected to reach more than 10 million Eur.
Last year, the Lithuanian biotechnology sector grew by almost 87 percent. The income of companies in this sector amounted to close to 2 billion and the value-added reached 2.5% of the country’s GDP. In total, over the last decade, the revenue of the Lithuanian biotechnology sector has increased nine times – from 226 million EUR in 2010 to almost 2 billion EUR in 2020. According to dr. Gediminas Pauliukevičius, CEO of Northtown Vilnius, operator of Vilnius City Innovation Industrial Park, the Lithuanian biotechnology and life sciences sector has been distinguished for many years by its productivity and impressive performance results.
Lithuania’s goal to substantially grow its life sciences sector rests on the creation of an enabling environment for domestic and foreign companies alike. Vilnius City Innovation Industrial Park — established in August 2018 to provide a home for high-tech companies undertaking research and development (R&D) and production — aims to do just that. “Our vision is for VCIIP to mobilize a strong core of expertise and collaboration in the life sciences. As a park operator, we want the best possible conditions for the creation, growth, and co-operation of life sciences industry players,” says Gediminas Pauliukevičius, chief executive of Northtown Vilnius
The Vilnius City Innovation Industrial Park is refining its recipe for collaboration between business and science. “We have practically everything,” says Gediminas Pauliukevičius, the CEO of Northtown Vilnius, the operator of the industrial park. “VCIIP is a territory with fully developed infrastructure and communications, surrounded by pine forests, not far from the center of Vilnius.” Since beginning operations in August 2018, some 12 companies have either settled or are beginning to set up at VCIIP, covering areas ranging from the laser and photovoltaic technology to medicine and biopharmaceuticals.
In the April/May 2021 issue, fDi Intelligence magazine, provided by the specialist team of Financial Times, published a special report – Vilnius bolsters its biotech credentials. The report includes an article on how research expertise in Lithuania is coalescing, an interview with the CEO of Northtown Vilnius on plans to create a research and development hub, a review of how VCIIP has created a home for start-ups and mature companies, and an interview with the minister for economy and innovation about developing the life sciences ecosystem.
Investors establishing at Vilnius City Innovation Industrial Park will not be subject to the infrastructure development charge
The exception that the infrastructure development charge is not paid by the companies establishing at VCIIP, is provided by Article 15 of the Law on Municipal Infrastructure Development, which states that infrastructure development charge is not applied for the construction or reconstruction of buildings of state importance or in the territory of a project of state importance, the boundaries of which are established by the Government. VCIIP was granted the status of national importance economic project in 2015.
Advanced imaging and sensor systems developer “Tonbo Imaging” will establish at Vilnius City Innovation Industrial Park
“Tonbo Imaging”, a high-tech company developing advanced imaging and sensor systems and intelligent transport technology, will start operating in a universal production building at Vilnius City Innovation Industrial Park. “Tonbo Imaging” will start operating starting early April, where a research and production centre for photonics and laser technologies, and intelligent transport systems will be established. It is estimated that investments in operational equipment will amount to about 1 million Eur.
“Imunodiagnostika”, a company developing the first Lithuanian Covid-19 antibody test, will establish in Vilnius City Innovation Industrial Park
Concentrating on the development of advanced diagnostic systems for nearly a decade now, “Imunodiagnostika” will establish in Vilnius City Innovation Industrial Park. By 2022, the company will build an innovative factory and scientific laboratory for the development of new products. It is estimated that the investments of “Imunodiagnostika” will reach 2.2 million. Eur, and about 50 new jobs will be created.
A group of companies managed by “Investment Projects” is establishing in Vilnius City Innovation Industrial Park to develop construction digitization tools.
On 30th of December 2020, the operator of Vilnius City Innovation Industrial Park signed an agreement on the establishment of a group of companies managed by “Investment Projects” at VCIIP. Companies plan to establish a testing and production base on site to create and develop tools allowing better use of the possibilities of designing in the Building Information Modeling (BIM) environment.